Who Are We

RadBio-Q LLC consulting and applied R&D efforts will pioneer fundamental unique approaches for advancing convergence by facilitating the transdisciplinary integration of life sciences, physical sciences, engineering, and computational science with AI. Our research and innovation leverage quantitative imaging, medical physics, radiation biology, and biomedical informatics to ensure diagnostics and treatments can achieve precision medicine quality results for therapeutics, image-guided intervention, and targeted drug & radiation combination therapies to improve treatment outcomes.

The company is committed to infusing the benefits of convergence to best serve innovation in biomedical research and medicine to improve patient outcomes. We aim to bring together knowledge experts and promote the execution to reach superior achievements for clients and advance precision medicine. We accomplish this by adhering to a set of principles that sustains convergence.

This convergence provides the power to think beyond usual paradigms and to approach issues informed by many perspectives instead of a few. Bringing together the insights enabled by rapid progress across multiple disciplines has the potential to transform science for the benefit of society. This is because the potential for innovation and successful problem-solving becomes more significant when we can harness individuals’ knowledge bases, skill sets, and diversity of experience. By merging these diverse areas of expertise in a network of partnerships, convergence stimulates innovation from basic science discovery to translational application.

The convergence of expertise necessary to address a set of research problems and the formation of effective partnerships involved in supporting such scientific investigations and enabling the resulting advances to be translated into new forms of innovation and new products are the milestone objectives of the company in its ability to bring about personalized medicine solutions to humanity.

Our Mission

RadBio-Q is an advanced technology that harnesses the power of AI to enhance human creativity and tackle the obstacles faced in democratizing innovation. By combining the principles of radiation biology and artificial intelligence, RadBio-Q opens up new possibilities for generating and identifying novel ideas and solutions to improve the quality of health. It addresses the following key challenges:

What We Do

Challenging expertise bias
Assist in idea evaluation that contributes to use-inspired translation R&D towards innovation creation
Support solution development that considers systemic imaging contributions
Facilitate collaboration in multidisciplinary and transdisciplinary environments and allow users to go beyond the boundaries of discovery

In our corporate environment, knowledge created by the process of convergence can contribute to

01.

Understanding

Complex biological systems with quantum biotechnology, quantitative Imaging, and radiation biology to understand, design, investigate, and generate new understanding for predictive radiation oncology and the latest cancer treatments.

02.

Improving

Patient outcomes through integrated knowledge with generative AI to promote divergent thinking for innovation to advance precision medicine solutions.

03.

Revolutionizing

Biomanufacturing through advances in digital twin technology and automated three-dimensional printing of biological system interaction to understand disease progression.